4N8-31801-35062
3 vaccinations
0 coded responses
25 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 762 / TX
- Registered
- 2021-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-29
Registered in v-safe
-
2021-12-29
Dose 2 — Moderna
- 2021-12-29
-
2021-12-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-12-31
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-02-11
- 2022-03-30
-
2022-11-25
Dose 3 — Pfizer-BioNTech
- 2022-11-25
-
2022-11-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-11-27
- 2022-11-28
- 2022-11-29
- 2022-11-30
- 2022-12-01
- 2022-12-04
- 2022-12-09
- 2022-12-16
- 2023-01-01
- 2023-01-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-29 | Moderna | No |
| 3 | 2022-11-25 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.